FR3096888B1 - Lentille biologique comprenant une membrane amniotique - Google Patents

Lentille biologique comprenant une membrane amniotique Download PDF

Info

Publication number
FR3096888B1
FR3096888B1 FR1905931A FR1905931A FR3096888B1 FR 3096888 B1 FR3096888 B1 FR 3096888B1 FR 1905931 A FR1905931 A FR 1905931A FR 1905931 A FR1905931 A FR 1905931A FR 3096888 B1 FR3096888 B1 FR 3096888B1
Authority
FR
France
Prior art keywords
amniotic membrane
lens including
biological
biological lens
lenses
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR1905931A
Other languages
English (en)
Other versions
FR3096888A1 (fr
Inventor
Laurence Barnouin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
TBF Genie Tissulaire
Original Assignee
TBF Genie Tissulaire
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by TBF Genie Tissulaire filed Critical TBF Genie Tissulaire
Priority to FR1905931A priority Critical patent/FR3096888B1/fr
Priority to PCT/EP2020/065565 priority patent/WO2020245324A1/fr
Priority to EP20729774.8A priority patent/EP3980087B1/fr
Publication of FR3096888A1 publication Critical patent/FR3096888A1/fr
Application granted granted Critical
Publication of FR3096888B1 publication Critical patent/FR3096888B1/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3604Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/52Hydrogels or hydrocolloids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54Biologically active materials, e.g. therapeutic substances
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00Materials or treatment for tissue regeneration
    • A61L2430/16Materials or treatment for tissue regeneration for reconstruction of eye parts, e.g. intraocular lens, cornea

Abstract

LENTILLE BIOLOGIQUE COMPRENANT UNE MEMBRANE AMNIOTIQUE La présente invention concerne le domaine des lentilles biologiques appelées également « lentilles pansement » qui comprennent une membrane amniotique et sont utilisées notamment pour des applications médicales, par exemple dans le traitement des surfaces oculaires. La présente invention concerne également un procédé de fabrication d’une telle lentille biologique ainsi qu’un support pour son montage.
FR1905931A 2019-06-04 2019-06-04 Lentille biologique comprenant une membrane amniotique Active FR3096888B1 (fr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
FR1905931A FR3096888B1 (fr) 2019-06-04 2019-06-04 Lentille biologique comprenant une membrane amniotique
PCT/EP2020/065565 WO2020245324A1 (fr) 2019-06-04 2020-06-04 Lentille biologique comprenant une membrane amniotique
EP20729774.8A EP3980087B1 (fr) 2019-06-04 2020-06-04 Lentille biologique comprenant une membrane amniotique

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1905931A FR3096888B1 (fr) 2019-06-04 2019-06-04 Lentille biologique comprenant une membrane amniotique
FR1905931 2019-06-04

Publications (2)

Publication Number Publication Date
FR3096888A1 FR3096888A1 (fr) 2020-12-11
FR3096888B1 true FR3096888B1 (fr) 2021-06-25

Family

ID=69375375

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1905931A Active FR3096888B1 (fr) 2019-06-04 2019-06-04 Lentille biologique comprenant une membrane amniotique

Country Status (1)

Country Link
FR (1) FR3096888B1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN117679209A (zh) * 2023-12-25 2024-03-12 山东第一医科大学附属眼科医院(山东省眼科医院) 免缝眼用生物羊膜

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI290055B (en) 2002-03-14 2007-11-21 Tissuetech Inc Amniotic membrane covering for a tissue surface and devices facilitating fastening of membranes
DE102006019017B4 (de) 2006-04-13 2016-09-22 Leibniz-Institut Für Polymerforschung Dresden E.V. Haltevorrichtung für eine Membran, Träger für die Haltevorrichtung und Verfahren zum Fixieren der Membran mittels der Haltevorrichtung an einem Auge
US8071135B2 (en) * 2006-10-04 2011-12-06 Anthrogenesis Corporation Placental tissue compositions
WO2016138025A2 (fr) 2015-02-23 2016-09-01 Tissuetech, Inc. Appareils et méthodes de traitement de maladies et de troubles ophtalmiques
FR3047899A1 (fr) 2016-02-18 2017-08-25 Tbf - Genie Tissulaire Et Par Abreviation Tbf Procede de preparation d'un materiau d'allogreffe, produit obtenu, et utilisations de celui-ci
FR3070262B1 (fr) 2017-08-23 2020-10-16 Tbf Genie Tissulaire Tbf Composition comprenant de la gelee de wharton, procede de preparation et utilisations

Also Published As

Publication number Publication date
FR3096888A1 (fr) 2020-12-11

Similar Documents

Publication Publication Date Title
MA45029A (fr) Anticorps anti pd-1 et anti-lag3 pour le traitement du cancer
MA39250B1 (fr) Protéines hybrides de l'interleukine-2 et leurs utilisations
MA49809A1 (fr) Composés utilisés comme inhibiteurs de kinase
FR3082123B1 (fr) Pansement cellularise et son procede de fabrication
MA43335B1 (fr) Compositions d'arni de transthyrétine (ttr) et procédés pour les utiliser pour le traitement ou la prévention de maladies associées à ttr
FR3096888B1 (fr) Lentille biologique comprenant une membrane amniotique
MA41072A1 (fr) Nouvelles protéines spécifiques de la pyoverdine et de la pyochéline
MA58208B1 (fr) Acides nucléiques pour inhiber l'expression de lpa dans une cellule
MA47736B1 (fr) Pyrimidopyrimidinones utiles en tant qu'inhibiteurs de la kinase wee-1
MA53268B1 (fr) Mini-gde pour le traitement de maladies de stockage de glycogène de type iii
MA35129B1 (fr) Traitement du myélome multiple
MA37946A1 (fr) Traitement de la polyarthrite rhumatoïde
MA34724B1 (fr) Nouvelle forme d'administration d'un inhibiteur de l'enképhalinase
MA46548A (fr) Fsh pour le traitement de l'infertilité
MX2020007036A (es) Combinaciones de inhibidores ripk1 e ikk para la prevención o tratamiento de enfermedades inmunitarias.
MA46235B1 (fr) 1-aryl-naphtyridin-3-ylcarboxamides substitués en position 7 et leur utilisation
FR3056398B1 (fr) Ventouse de massage
FR3070263B1 (fr) Composition pour son utilisation dans le traitement et/ou la prevention de l’infertilite
DE602006002806D1 (fr)
FR3098714B1 (fr) Procédé de traitement des fibres kératiniques associant une composition comprenant un silicate hydrosoluble et une composition comprenant un acide aminé et/ou un oligopeptide
MA51297B1 (fr) Quinazolinones en tant qu'inhibiteurs de parp14
FR3103106B1 (fr) Extrait liquide aqueux de Spiruline pour la prévention et/ou le traitement des neuropathies périphériques chimio-induites et leurs symptômes, composition et utilisation correspondantes.
MA62937B1 (fr) Compositions d'arni d'angiotensinogène (agt) et leurs procédés d'utilisation
Doxzen et al. Making Gene Therapy Accessible
MA51973B1 (fr) Inhibiteurs de glycolate oxydase de triazole

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 2

PLSC Publication of the preliminary search report

Effective date: 20201211

PLFP Fee payment

Year of fee payment: 3

PLFP Fee payment

Year of fee payment: 4

PLFP Fee payment

Year of fee payment: 5